Frazier Life Sciences Management, L.P. ARQT Holdings History
Frazier Life Sciences Management, L.P.'s Arcutis Biotherapeutics Inc Holding Summary
As of 2025-03-31, Frazier Life Sciences Management, L.P. held 8.79 Mil shares of Arcutis Biotherapeutics Inc(ARQT), totaling $137.40 Mil. This investment constitutes 6.28% of their stock portfolio, and Frazier Life Sciences Management, L.P. now holds 7.37% of the outstanding Arcutis Biotherapeutics Inc(ARQT) stock.
The initial trade took place in 2022Q1. And since then Frazier Life Sciences Management, L.P. has made 3 purchases of ARQT, at an average price of $16.92, for a total of 8.79 Mil shares. Based on historical transaction data and ARQT's current price of $15.63, Frazier Life Sciences Management, L.P.'s estimated gain on his ARQT holdings is $-11.35 Mil, reflecting a -7.63% gain to date.
Frazier Life Sciences Management, L.P. ARQT ($15.63) Holding Chart
Frazier Life Sciences Management, L.P. ARQT ($15.63) Quarterly Buys and Sells
Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
---|---|---|---|---|
Shares Bought | 0 | Average Price $-/Share | ||
Shares Sold | 0 | Average Price $-/Share | ||
Current Price $0.00 | Total Estimated Gain 0 % |
Top Ranked Articles
- 1